Skip to menu Skip to content Skip to footer
Professor Brandon Wainwright
Professor

Brandon Wainwright

Email: 
Phone: 
*

Overview

Background

Professor Brandon Wainwright AM is Co-Director of the Children’s Brain Cancer Centre and leads a laboratory within the UQ Diamantina Institute focused on understanding the genetic pathways behind medulloblastoma, a type of brain tumour that occurs predominantly in children. He is Chair of the European Molecular Biology Laboratory (EMBL) Australia, Chair of the Advisory Board of the Robinson Research Institute and Chair of the Board of the South Australian Immunogenomics Cancer Institute (SAIGENCI), and serves on the boards the Australian Genome Research Facility as well as several national and international scientific review committees, including the MRFF Brain Tumour Roadmap Committee.

Professor Wainwright completed his undergraduate and postgraduate studies at The University of Adelaide, after which he secured a postdoctoral fellowship with St Mary's Hospital at Imperial College London. During his six years at Imperial he worked on the first human genome project and also became a Medical Research Council Senior Research Fellow. He returned to Australia in 1990 to join UQ's Centre for Molecular and Cellular Biology (now IMB) and led the Institute for Molecular Biology until 2019.

Professor Wainwright is a geneticist, renowned for discovering the genetic pathway that causes most human cancer. He is skilled in molecular genetics, where he is using genetic approaches to dig through DNA and find the genes that cause disease. He commenced using these skills to locate the cystic fibrosis gene, but it was when isolating a gene responsible for a rare form of brain cancer called Medulloblastoma, that he discovered the role of the ‘Hedgehog Pathway' in common human cancer.

Availability

Professor Brandon Wainwright is:
Available for supervision
Media expert

Research interests

  • Cancer and cell signalling

    Skin cancer is a major public health issue in Australia, with the treatment of non-melanoma skin cancer costing our community more than $264 million each year. Moreover, brain tumours remain the most common cause of cancer-related death in children and of these, medulloblastoma is the most commonly diagnosed. Our laboratory has made great progress in understanding the genetic pathways behind the most common form of skin cancer in Australia, Basal Cell Carcinoma (BCC), and medulloblastoma, a type of brain tumour that occurs predominantly in children. Having mapped and isolated the Naevoid Basel Cell Carcinoma Syndrome (NBCCS) gene called Patched, which is the driver for a medical condition where affected individuals have a predisposition for developing BCC and medulloblastoma, we were able to identify the Patched gene as a controller of a molecular signalling pathway called the Hedgehog pathway. The Hedgehog pathway is a set of genetic mutations that contribute to the development of a wide range of tumour types, including lung, pancreatic and ovarian cancer. By examining this pathway and how it interacts with other genetic pathways, our scientists have gained a better understanding of the normal development of the skin and cerebellum, a part of the brain that controls motor functions. By manipulating the strength of the Hedgehog pathway we believe stem cell populations can be expanded or can be induced to become cancerous. Our lab has identified the core genetic components that lead to the development of medulloblastoma. This work will enable the therapeutic targeting of every medulloblastoma, not just a subset, leading to more powerful clinical trials and ultimately more effective treatment options.

Works

Search Professor Brandon Wainwright’s works on UQ eSpace

168 works between 1985 and 2024

1 - 20 of 168 works

2024

Conference Publication

Germline ELP1 deficiency sensitizes cerebellar granule neuron progenitors to SHH medulloblastoma

Ahmad, Shiekh Tanveer, Garcia-Lopez, Jesus, Li, Yiran, Gudenas, Brian, Hadley, Jennifer, Paul, Leena, Batts, Melissa, Soliman, Taha, Kojic, Marija, Pitre, Aaron, Manz, Frederik, Zindy, Frederique, Jones, Alun, Mayasundari, Anand, Bianski, Brandon, Tinkle, Christopher, Shirinifard, Abbas, Janke, Laura, Lu, Meifen, Pfister, Stefan M., Gajjar, Amar, Baker, Suzanne J., Roussel, Martine F., Rankovic, Zoran, Waszak, Sebastian M., Robinson, Giles W., Orr, Brent A., Wainwright, Brandon, Kutscher, Lena M. ... Northcott, Paul A. (2024). Germline ELP1 deficiency sensitizes cerebellar granule neuron progenitors to SHH medulloblastoma. International Symposium on Pediatric Neuro-Oncology (ISPNO), Philadelphia, PA, United States, 29 June - 2 July 2024. Cary, NC, United States: Oxford University Press. doi: 10.1093/neuonc/noae064.462

Germline ELP1 deficiency sensitizes cerebellar granule neuron progenitors to SHH medulloblastoma

2024

Journal Article

The Virtual Child

Gilbertson, Richard J., Behjati, Sam, Böttcher, Anna-Lisa, Bronner, Marianne E., Burridge, Matthew, Clausing, Henrick, Clifford, Harry, Danaher, Tracey, Donovan, Laura K., Drost, Jarno, Eggermont, Alexander M.M., Emerson, Chris, Flores, Mona G., Hamerlik, Petra, Jabado, Nada, Jones, Andrew, Kaessmann, Henrick, Kleinman, Claudia L., Kool, Marcel, Kutscher, Lena M., Lindberg, Gavin, Linnane, Emily, Marioni, John C., Maris, John M., Monje, Michelle, Macaskill, Alexandra, Niederer, Steven, Northcott, Paul A., Peeters, Elizabeth ... Pfister, Stefan M. (2024). The Virtual Child. Cancer Discovery, 14 (4), 663-668. doi: 10.1158/2159-8290.cd-23-1500

The Virtual Child

2023

Journal Article

Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors

Endersby, Raelene, Wainwright, Brandon J. and Gottardo, Nicholas G. (2023). Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors. Frontiers in Oncology, 13 1274465. doi: 10.3389/fonc.2023.1274465

Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors

2023

Journal Article

Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening

Kojic, Marija, Maybury, Mellissa K., Waddell, Nicola, Koufariotis, Lambros T., Addala, Venkateswar, Millar, Amanda, Wood, Scott, Pearson, John V., Hansford, Jordan R., Hassall, Tim and Wainwright, Brandon J. (2023). Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening. Neuro-Oncology, 25 (8), 1507-1517. doi: 10.1093/neuonc/noad032

Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening

2023

Conference Publication

Uncovering Dynamic Changes In Medulloblastoma Associated Vasculature In Zebrafish

Morris, Elysse, Daignault-Mill, Sheena, Ju, Robert J., da Silva, Jason, Gordon, Emma, Wainwright, Brandon, Stehbens, Samantha, Genovesi, Laura and Lagendijk, Anne (2023). Uncovering Dynamic Changes In Medulloblastoma Associated Vasculature In Zebrafish. 2023 Pediatric Neuro-Oncology Research Conference, Washington, DC United States, 22-24 June 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/neuonc/noad073.274

Uncovering Dynamic Changes In Medulloblastoma Associated Vasculature In Zebrafish

2023

Conference Publication

ELP1 Germline Deficiency Sensitizes The Granule Neuron Lineage To SHH Medulloblastoma And Exposes Novel Therapeutic Vulnerabilities

Garcia-Lopez, Jesus, Ahmad, Shiekh Tanveer, Li, Yiran, Gudenas, Brian, Kojic, Marija, Manz, Friedrik, Jonchere, Barbara, Mayasundari, Anand, Pitre, Aaron, Hadley, Jennifer, Paul, Leena, Batts, Melissa, Pfister, Stefan, Waszak, Sebastian, Bianski, Brandon, Tinkle, Christopher, Orr, Brent, Rankovic, Zoran, Robinson, Giles, Wainwright, Brandon, Kutscher, Lena, Lin, Hong and Northcott, Paul (2023). ELP1 Germline Deficiency Sensitizes The Granule Neuron Lineage To SHH Medulloblastoma And Exposes Novel Therapeutic Vulnerabilities. 2023 Pediatric Neuro-Oncology Research Conference, Washington, DC United States, 22-24 June 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/neuonc/noad073.255

ELP1 Germline Deficiency Sensitizes The Granule Neuron Lineage To SHH Medulloblastoma And Exposes Novel Therapeutic Vulnerabilities

2023

Journal Article

Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition

Vo, Tuan, Balderson, Brad, Jones, Kahli, Ni, Guiyan, Crawford, Joanna, Millar, Amanda, Tolson, Elissa, Singleton, Matthew, Kojic, Marija, Robertson, Thomas, Walters, Shaun, Mulay, Onkar, Bhuva, Dharmesh D., Davis, Melissa J., Wainwright, Brandon J., Nguyen, Quan and Genovesi, Laura A. (2023). Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition. Genome Medicine, 15 (1) 29, 29. doi: 10.1186/s13073-023-01185-4

Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition

2023

Journal Article

A novel ELP1 mutation impairs the function of the Elongator complex and causes a severe neurodevelopmental phenotype

Kojic, Marija, Abbassi, Nour E. H., Lin, Ting-Yu, Jones, Alun, Wakeling, Emma L., Clement, Emma, Nakou, Vasiliki, Singleton, Matthew, Dobosz, Dominika, Kaliakatsos, Marios, Glatt, Sebastian and Wainwright, Brandon J. (2023). A novel ELP1 mutation impairs the function of the Elongator complex and causes a severe neurodevelopmental phenotype. Journal of Human Genetics, 68 (7), 445-453. doi: 10.1038/s10038-023-01135-3

A novel ELP1 mutation impairs the function of the Elongator complex and causes a severe neurodevelopmental phenotype

2023

Journal Article

Elongator and the role of its subcomplexes in human diseases

Gaik, Monika, Kojic, Marija, Wainwright, Brandon J and Glatt, Sebastian (2023). Elongator and the role of its subcomplexes in human diseases. EMBO Molecular Medicine, 15 (2) e16418, e16418. doi: 10.15252/emmm.202216418

Elongator and the role of its subcomplexes in human diseases

2022

Journal Article

Functional divergence of the two Elongator subcomplexes during neurodevelopment

Gaik, Monika, Kojic, Marija, Stegeman, Megan R., Öncü‐Öner, Tülay, Kościelniak, Anna, Jones, Alun, Mohamed, Ahmed, Chau, Pak Yan Stefanie, Sharmin, Sazia, Chramiec‐Głąbik, Andrzej, Indyka, Paulina, Rawski, Michał, Biela, Anna, Dobosz, Dominika, Millar, Amanda, Chau, Vann, Ünalp, Aycan, Piper, Michael, Bellingham, Mark C., Eichler, Evan E., Nickerson, Deborah A., Güleryüz, Handan, Abbassi, Nour El Hana, Jazgar, Konrad, Davis, Melissa J., Mercimek‐Andrews, Saadet, Cingöz, Sultan, Wainwright, Brandon J. and Glatt, Sebastian (2022). Functional divergence of the two Elongator subcomplexes during neurodevelopment. EMBO Molecular Medicine, 14 (7) e15608, e15608. doi: 10.15252/emmm.202115608

Functional divergence of the two Elongator subcomplexes during neurodevelopment

2022

Conference Publication

MEDB-06. Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that loss of heterogeneity and induced differentiation underlies the response to CDK4/6 inhibition

Vo, Tuan, Balderson, Brad, Jones, Kahli, Crawford, Joanna, Millar, Amanda, Tolson, Elissa, Ruitenberg, Marc, Robertson, Thomas, Bhuva, Dharmesh, Davis, Melissa, Wainwright, Brandon, Nguyen, Quan and Genovesi, Laura (2022). MEDB-06. Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that loss of heterogeneity and induced differentiation underlies the response to CDK4/6 inhibition. International Symposium on Pediatric Neuro-Oncology, Hamburg, Germany, 12–15 June 2022. Cary, NC, United States: Oxford University Press. doi: 10.1093/neuonc/noac079.381

MEDB-06. Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that loss of heterogeneity and induced differentiation underlies the response to CDK4/6 inhibition

2021

Journal Article

SOX9 defines distinct populations of cells in SHH medulloblastoma but is not required for Math1-driven tumour formation

Adolphe, Christelle, Millar, Amanda, Kojic, Marija, Barkauskas, Deborah S., Sundstrom, Anders, Swartling, Fredrik J., Hediyeh-zadeh, Soroor, Tan, Chin Wee, Davis, Melissa J., Genovesi, Laura A. and Wainwright, Brandon J. (2021). SOX9 defines distinct populations of cells in SHH medulloblastoma but is not required for Math1-driven tumour formation. Molecular Cancer Research, 19 (11), 1831-1839. doi: 10.1158/1541-7786.mcr-21-0117

SOX9 defines distinct populations of cells in SHH medulloblastoma but is not required for Math1-driven tumour formation

2021

Journal Article

Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse

Guo, Duancheng, Wang, Yuan, Cheng, Yan, Liao, Shengyou, Hu, Jian, Du, Fang, Xu, Gang, Liu, Yongqiang, Cai, Kathy Q., Cheung, Martin, Wainwright, Brandon J., Lu, Q. Richard, Zhao, Yi and Yang, Zeng-jie (2021). Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse. Journal of Experimental Medicine, 218 (9) e20202350, 1-18. doi: 10.1084/jem.20202350

Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse

2021

Journal Article

Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma

Genovesi, Laura A., Millar, Amanda, Tolson, Elissa, Singleton, Matthew, Hassall, Emily, Kojic, Marija, Brighi, Caterina, Girard, Emily, Andradas, Clara, Kuchibhotla, Mani, Bhuva, Dharmesh D., Endersby, Raelene, Gottardo, Nicholas G., Bernard, Anne, Adolphe, Christelle, Olson, James M., Taylor, Michael D., Davis, Melissa J. and Wainwright, Brandon J. (2021). Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma. Genome Medicine, 13 (1) 103, 103. doi: 10.1186/s13073-021-00920-z

Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma

2021

Journal Article

Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype

Kojic, Marija, Gawda, Tomasz, Gaik, Monika, Begg, Alexander, Salerno-Kochan, Anna, Kurniawan, Nyoman D., Jones, Alun, Drożdżyk, Katarzyna, Kościelniak, Anna, Chramiec-Głąbik, Andrzej, Hediyeh-Zadeh, Soroor, Kasherman, Maria, Shim, Woo Jun, Sinniah, Enakshi, Genovesi, Laura A., Abrahamsen, Rannvá K., Fenger, Christina D., Madsen, Camilla G., Cohen, Julie S., Fatemi, Ali, Stark, Zornitza, Lunke, Sebastian, Lee, Joy, Hansen, Jonas K., Boxill, Martin F., Keren, Boris, Marey, Isabelle, Saenz, Margarita S., Brown, Kathleen ... Wainwright, Brandon J. (2021). Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype. Nature Communications, 12 (1) 2678, 2678. doi: 10.1038/s41467-021-22888-5

Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype

2021

Journal Article

Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release

Starobova, Hana, Monteleone, Mercedes, Adolphe, Christelle, Batoon, Lena, Sandrock, Cheyenne J., Tay, Bryan, Deuis, Jennifer R., Smith, Alexandra V., Mueller, Alexander, Nadar, Evelyn Israel, Lawrence, Grace Pamo, Mayor, Amanda, Tolson, Elissa, Levesque, Jean-Pierre, Pettit, Allison R., Wainwright, Brandon J., Schroder, Kate and Vetter, Irina (2021). Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release. Journal of Experimental Medicine, 218 (5) e20201452. doi: 10.1084/jem.20201452

Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release

2021

Journal Article

Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility

Adolphe, Christelle, Xue, Angli, Fard, Atefeh Taherian, Genovesi, Laura A., Yang, Jian and Wainwright, Brandon J. (2021). Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility. Genome Medicine, 13 (1) 19, 19. doi: 10.1186/s13073-021-00827-9

Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility

2020

Journal Article

Patient derived orthotopic xenograft models of Medulloblastoma lack a functional blood brain barrier

Genovesi, Laura A., Puttick, Simon, Millar, Amanda, Kojic, Marija, Ji, Pengxiang, Lagendijk, Anne K., Brighi, Caterina, Bonder, Claudine S, Adolphe, Christelle and Wainwright, Brandon J. (2020). Patient derived orthotopic xenograft models of Medulloblastoma lack a functional blood brain barrier. Neuro-Oncology, 23 (5), 732-742. doi: 10.1093/neuonc/noaa266

Patient derived orthotopic xenograft models of Medulloblastoma lack a functional blood brain barrier

2020

Journal Article

Germline elongator mutations in Sonic Hedgehog medulloblastoma

Waszak, Sebastian M., Robinson, Giles W,, Gudenas, Brian L., Smith, Kyle S., Forget, Antoine, Kojic, Marija, Garcia-Lopez, Jesus, Hadley, Jennifer, Hamilton, Kayla V., Indersie, Emilie, Buchhalter, Ivo, Kerssemakers, Jules, Jäger, Natalie, Sharma, Tanvi, Rausch, Tobias, Kool, Marcel, Sturm, Dominik, Jones, David T. W., Vasilyeva, Aksana, Tatevossian, Ruth G., Neale, Geoffrey, Lombard, Bérangère, Loew, Damarys, Nakitandwe, Joy, Rusch, Michael, Bowers, Daniel C., Bendel, Anne, Partap, Sonia, Chintagumpala, Murali ... Pfister, Stefan M. (2020). Germline elongator mutations in Sonic Hedgehog medulloblastoma. Nature, 580 (7803), 396-401. doi: 10.1038/s41586-020-2164-5

Germline elongator mutations in Sonic Hedgehog medulloblastoma

2020

Journal Article

Ectopic expression of SOX18 in Basal cell carcinoma negatively regulates tumour progression

Villani, Rehan, Sim, Seen Ling, Roy, Edwige, Wainwright, Brandon, Francois, Mathias and Khosrotehrani, Kiarash (2020). Ectopic expression of SOX18 in Basal cell carcinoma negatively regulates tumour progression. Journal of Dermatological Science, 98 (3), 179-185. doi: 10.1016/j.jdermsci.2020.04.006

Ectopic expression of SOX18 in Basal cell carcinoma negatively regulates tumour progression

Funding

Current funding

  • 2024 - 2029
    Building mRNA Cancer Vaccines for Australia.
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2023 - 2027
    A vaccine to treat paediatric brain cancer
    The Trustee for the Robert Connor Dawes Foundation
    Open grant
  • 2023 - 2024
    Engineering Immune Recognition of Paediatric Brain Tumours
    Walter & Eliza Hall Institute of Medical Research (WEHI)
    Open grant
  • 2019 - 2025
    Centre for Child and Adolescent Brain Cancer Research
    The Children's Hospital Foundation
    Open grant

Past funding

  • 2022 - 2024
    A new combination therapy for children with brain cancer
    Soiree For a Cure
    Open grant
  • 2022 - 2024
    A new and effective combination therapy for children with brain cancer (TKCP)
    The Kid's Cancer Project
    Open grant
  • 2021 - 2023
    Targeting and eliminating paediatric cancers with chimeric antigen receptor engineered natural killer cells, a new hope for cancer immunotherapy
    Children's Hospital Foundation Immunotherapy Research Grants
    Open grant
  • 2021 - 2024
    Identification of therapy-resistant cells driving relapse in Medulloblastoma from integrated spatial transcriptomics and tissue imaging
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2021
    Developing treatments for vincristine-induced neuropathy
    The Kid's Cancer Project
    Open grant
  • 2019 - 2022
    Exploiting CDK4/6 inhibition to treat medulloblastoma.
    Cancer Australia
    Open grant
  • 2019 - 2020
    Liquid biopsy (CSF) in paediatric brain cancer patients
    Brainchild Foundation
    Open grant
  • 2017 - 2024
    ACRF Cancer Ultrastructure and Function Facility
    Australian Cancer Research Foundation
    Open grant
  • 2016 - 2019
    Targeting the cell cycle regulators CDK4/6 to treat medulloblastoma
    The Kid's Cancer Project
    Open grant
  • 2016 - 2019
    Cure Brain Cancer Foundation Donation
    Cure Brain Cancer Foundation
    Open grant
  • 2016 - 2021
    Preparing Australia for Genomic Medicine: A proposal by the Australian Genomics Health Alliance (NHMRC Targeted Call for Research administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant
  • 2016
    4D Mass Spectrometer
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    A Synthetic lethal based approach for the treatment of medulloblastoma
    Cancer Council Queensland
    Open grant
  • 2014 - 2016
    Establishment of patient-derived xenografts from paediatric brain tumours to facilitate a personalised genomic approach to treatment
    Brainchild Foundation
    Open grant
  • 2012 - 2014
    Identification of genes causing medulloblastoma by transposon mutagenesis.
    NHMRC Project Grant
    Open grant
  • 2010 - 2012
    The intersection between hedgehog and notch signalling in medulloblastoma.
    NHMRC Project Grant
    Open grant
  • 2010 - 2013
    The primary cilium in hedgehog signalling and disease
    NHMRC Project Grant
    Open grant
  • 2009 - 2016
    The ACRF Cancer Biology Imaging Facility
    Australian Cancer Research Foundation
    Open grant
  • 2009 - 2014
    International Cancer Genome Consortium
    NHMRC Medical Bioinformatics Genomics Proteomics Program
    Open grant
  • 2009 - 2012
    Dissecting the role of hedgehog signalling in chondrogenesis and skeletal disease
    NHMRC Project Grant
    Open grant
  • 2008 - 2009
    Kruppel-like factors in cell cycle control and cancer
    Cancer Council Queensland
    Open grant
  • 2008 - 2010
    Patched gene family control of epidermal development and cancer
    NHMRC Project Grant
    Open grant
  • 2008 - 2009
    Profiling the pro- and anti-inflammatory functions of histone deacetylases in macrophages
    Cancer Council Queensland
    Open grant
  • 2007 - 2008
    The Cellular Origin of Medulloblastoma
    Queensland Cancer Fund
    Open grant
  • 2006
    Advanced Cell Labelling and Imaging Facility
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2006 - 2008
    ERRgamma and skeletal muscle: Insights into lipid utilization and catabolism
    NHMRC Project Grant
    Open grant
  • 2006 - 2008
    Hedgehog signalling in limb and craniofacial development and disease
    NHMRC Project Grant
    Open grant
  • 2006 - 2008
    Molecular genetics of the host response defect in cystic fibrosis
    NHMRC Project Grant
    Open grant
  • 2006 - 2008
    NR1 nuclear hormone receptors, and skeletal muscle metabolism: Insights into dyslipidemia and metabolic disease.
    NHMRC Project Grant
    Open grant
  • 2004 - 2011
    Dynamic Imaging Facility for Cancer Biology
    Australian Cancer Research Foundation
    Open grant
  • 2004 - 2006
    The role of patched/hedgehog signalling in common human cancer
    NHMRC Project Grant
    Open grant
  • 2003
    Agilent Microarray Scanner
    NHMRC Equipment Grant
    Open grant
  • 2003
    Alternative Splicing in the Mouse Transcriptome
    ARC Discovery Projects
    Open grant
  • 2003 - 2005
    Molecular genetics of cystic fibrosis
    NHMRC Project Grant
    Open grant
  • 2003 - 2005
    Regulation Of Hedgehog Signalling Through Intracellular Trafficking Events
    NHMRC Project Grant
    Open grant
  • 2001 - 2003
    Conditional Knockout of the Murine Patched Gene for the Study of Skin Differentiation and Cancer
    NHMRC Project Grant
    Open grant
  • 2001 - 2003
    The Downstream Targets of Patched Hedgehog Signalling
    NHMRC Project Grant
    Open grant
  • 2001 - 2003
    The identification of the downstream targets of patched/hedgehog signalling
    Queensland Cancer Fund
    Open grant
  • 2000 - 2002
    Genes controlling the development of lung disease in cystic fibrosis mutant mice
    NHMRC Project Grant
    Open grant
  • 2000 - 2014
    State Government Funds
    Queensland Department of Employment, Economic Development and Innovation
    Open grant
  • 1999 - 2001
    Analysis and correction of the host response defect in cystic fibrosis G551D mice
    NHMRC Project Grant
    Open grant
  • 1999
    Avalanche microscanner
    NHMRC Equipment Grant
    Open grant
  • 1999 - 2000
    Targets of the patched/hedgehog signalling pathway in basal cell carcinoma of the skin and other solid tumours
    Queensland Cancer Fund
    Open grant
  • 1998 - 2000
    Inactivation of the Patched Tumour Suppressor Gene in the Skin of Transgenic Mice
    NHMRC Project Grant
    Open grant
  • 1998 - 2000
    Structure-Function Analysis of the PATCHED Tumour Suppressor Gene Product
    NHMRC Project Grant
    Open grant
  • 1998 - 1999
    The smoothened gene in skin development and tumour formation
    Queensland Cancer Fund
    Open grant
  • 1997 - 1999
    Genes controlling the development of lung disease in normal and cystic fibrosis mice
    NHMRC Project Grant
    Open grant
  • 1997 - 1998
    Mouse models for naevoid basal cell carcinoma syndrome and basal cell carcinoma
    Queensland Cancer Fund
    Open grant
  • 1997 - 1998
    The role of PTC, the naevoid basal cell carcinoma syndrome gene, in carcigenesis
    Queensland Cancer Fund
    Open grant
  • 1996 - 1998
    Correction of the ion channel defect in the airway of cystic fibrosis G551D mice
    NHMRC Project Grant
    Open grant
  • 1996
    Suppression of tumorigenicity in medulloblastoma
    Cancer Bequest Fund
    Open grant
  • 1995 - 1997
    Actions and interactions of the four alternately spliced WT1 protein isoforms
    NHMRC Project Grant - Standard
    Open grant
  • 1995
    Identification of cis-acting elements in the murine CFTR promoter
    UQ External Support Enabling Grant
    Open grant
  • 1995
    Identification of cis-acting elements in the murine CFTR promoter.
    Australian Cystic Fibrosis Research Trust
    Open grant
  • 1995 - 1997
    The isolation of the naevoid basal cell carcinoma syndrome gene
    NHMRC Project Grant - Standard
    Open grant
  • 1995
    Travel to attend the North American CF Conference, October 1995 and to confer with colleagues in the USA & UK.
    Royal Alexandra Hospital for Children - Camperdown
    Open grant

Supervision

Availability

Professor Brandon Wainwright is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    The role of the blood brain barrier in the successful treatment of brain tumours in children

    Principal Advisor

  • Doctor Philosophy

    New treatments for children with medulloblastoma.

    Principal Advisor

  • Doctor Philosophy

    A new therapy for paediatric brain tumours.

    Principal Advisor

    Other advisors: Dr Joseph Yunis

  • Doctor Philosophy

    Investigation into network-defined novel targeted therapies for medulloblastoma

    Associate Advisor

    Other advisors: Dr Laura Genovesi

  • Doctor Philosophy

    Complex neoantigen prediction in cancers

    Associate Advisor

    Other advisors: Dr Venkateswara Addala

Completed supervision

Media

Enquiries

Contact Professor Brandon Wainwright directly for media enquiries about:

  • brain cancer
  • brain tumour
  • genetics
  • genomics
  • health research
  • medical research
  • medulloblastoma
  • science policy
  • scientific leadership
  • skin cancer
  • tumours

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au